INT-767d (FXR/TGR5 agonist) in dogs: the evidence

What the aging-research databases and the canine literature hold for INT-767d (FXR/TGR5 agonist) (names searched: INT-767d (FXR/TGR5 agonist), INT 767d (FXR/TGR5 agonist), INT-767d-(FXR/TGR5-agonist), INT‐767d (FXR/TGR5 agonist)). Compiled from DrugAge, the canine aging corpus and FDA CVM FOI summaries; nothing here is inferred.

Lifespan experiments in other species (DrugAge)

2 experiments recorded, by species: Mus musculus 2.

NIA Interventions Testing Program rows

SpeciesStrainDoseAge at startDurationSexMean lifespan Δ%Mean sig.Max lifespan Δ%Max sig.Source
Mus musculusUM-HET3180 ppm food10 monthsuntil deathFemale-1NS0NSPMID 30688027
Mus musculusUM-HET3180 ppm food10 monthsuntil deathMale-3NS-4NSPMID 30688027

Lifespan experiments in dogs (DrugAge)

DrugAge records no dog lifespan experiment for this compound.

Dog-equivalent doses (allometric starting points, not recommendations)

Method: FDA 2005 Km body-surface-area conversion; starting-point heuristic only.

No mg/kg dose in DrugAge to translate (doses reported as ppm of diet or a concentration).

Canine aging literature (Europe PMC corpus)

0 corpus records mention this compound.

Trials and cohorts in the canine aging trial registry

No registered study of this compound in dogs.

FDA CVM FOI summaries for dog products

No FDA FOI summary for a dog product contains this ingredient (it is not a marketed veterinary product).

Evidence gaps reported by the dossier tool

Reproduce: intervention_dossier(compound="INT-767d (FXR/TGR5 agonist)") in dog-geroscience-mcp.